Clinical Trials

Showing 11-13 results of 13 total
Blood Disorders|Cancer

Study of REGN5458 plus Carfilzomib for multiple myeloma.

This trial is currently enrolling
The primary purpose of this study is to assess the safety and tolerability an investigational drug, REGN5458, combined with the current approved standard of...
Blood Disorders|Cancer

A study for patients with aggressive B-cell non-Hodgkin lymphoma.

This trial is currently enrolling
This study will evaluate the safety and tolerability of investigational drug IMPT-314. It will also help to determine the recommended phase 2 dosing.
Blood Disorders|Cancer

Study for patients with refractory/relapsed acute myeloid leukemia (AML).

This trial is currently enrolling
The purpose of this study is to determine the safety and tolerability of the investigational drug BP1002 in participants who have refractory/relapsed AML...